Clinical Trials · NCT01518985
The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 6
- Start date
- Jan 2012
- Locations
- 1 site, United States
- Primary endpoint
- Analysis of variance (ANOVA) between group mean endothelial function (EndoPAT Index) following smoking a single cigarette with and without Bendavia